# Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients

> **NCT06620393** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal** · enrollment: 72 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Agitation,Psychomotor

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06620393
- **Lead sponsor:** Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620393, "Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06620393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*